| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-2,107.3970 | -878.1120 | -189.8130 | -633.1760 | -1,229.2360 |
|
Exploration Expenses
|
-35.4190 | -35.4190 | -33.7270 | 0 | -- |
|
Taxes Other Than Income Taxes
|
0 | 0 | -23.5450 | 0 | -- |
|
Operating Income/Expenses
|
-2,204.9400 | -913.5310 | -247.0850 | -633.1760 | -1,229.2360 |
|
Total Operating Profit/Loss
|
-2,204.9400 | -913.5310 | -247.0850 | -633.1760 | -1,229.2360 |
| Total Net Finance Income/Expense
|
-5.4480 | -4.7140 | -8.8640 | -4.5720 | -3.3380 |
| Irregular Income/Expenses
|
-4.5010 | -4.5010 | -6,426.4230 | -1,871.7660 | -1,486.2590 |
|
Other Income/Expense, Non-Operating
|
0 | 0 | 3.4940 | 123.6330 | 155.6680 |
|
Non-Operating Income/Expenses, Total
|
309.2080 | -9.2150 | -6,431.7930 | -1,752.7050 | -1,333.9290 |
|
Pretax Income
|
-1,895.7320 | -922.7460 | -6,678.8780 | -2,385.8810 | -2,563.1650 |
|
Net Income from Continuing Operations
|
-1,895.7320 | -922.7460 | -6,678.8780 | -2,385.8810 | -2,563.1650 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-1,895.7320 | -922.7460 | -6,678.8780 | -2,385.8810 | -2,563.1650 |
|
Non-Controlling/Minority Interests
|
0 | 0 | 2.5670 | 630.8970 | 0 |
|
Net Income after Non-Controlling/Minority Interests
|
-1,895.7320 | -922.7460 | -6,676.3110 | -1,754.9840 | -2,563.1650 |
|
Net Income Available to Common Stockholders
|
-1,895.7320 | -922.7460 | -6,676.3110 | -1,754.9840 | -2,563.1650 |
|
Diluted Net Income Available to Common Stockholders
|
-1,895.7320 | -922.7460 | -6,676.3110 | -1,754.9840 | -2,563.1650 |
| Basic EPS
|
-0.10 | -0.07 | -0.72 | -0.20 | -0.40 |
| Diluted EPS
|
-0.10 | -0.07 | -0.72 | -0.20 | -0.40 |
|
Basic Weighted Average Shares Outstanding
|
18,937.7430 | 13,076.5740 | 9,263.4050 | 8,886.2020 | 6,423.8270 |
|
Diluted Weighted Average Shares Outstanding
|
18,937.7430 | 13,076.5740 | 9,263.4050 | 8,886.2020 | 6,423.8270 |
|
EBIT
|
-1,890.2840 | -918.0320 | -6,670.0140 | -2,381.3090 | -2,559.8270 |
|
EBITDA
|
-1,890.2840 | -918.0320 | -6,670.0140 | -2,381.3090 | -2,559.8270 |
|
Normalized EBITDA
|
-1,885.7830 | -499.4760 | -243.5910 | -447.3430 | -1,073.5680 |
|
Normalized Income
|
-1,891.2310 | -504.1900 | -252.4550 | -451.9150 | -1,076.9060 |
|
Total Unusual Items
|
4.5010 | 418.5560 | 6,426.4230 | 1,933.9660 | 1,486.2590 |
|
Total Unusual Items Excluding Goodwill
|
4.5010 | 418.5560 | 6,426.4230 | 1,933.9660 | 1,486.2590 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 | 0 |
|
Tax Rate, Calculated
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
12/31/2022 - 1/13/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade